Therapeutic Effect of Strontium Ranelate on Bone in Chemotherapy-Induced Osteopenic Rats via Increased Bone Volume and Reduced Bone Loss

[1]  L. Dupuis,et al.  2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy , 2016, Supportive Care in Cancer.

[2]  R. Mckinnon,et al.  Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats , 2016, Journal of Bone and Mineral Metabolism.

[3]  C. Cooper,et al.  Recent advances in the pathogenesis and treatment of osteoporosis. , 2015, Clinical medicine.

[4]  C. Cooper,et al.  The position of strontium ranelate in today’s management of osteoporosis , 2015, Osteoporosis International.

[5]  David Eglin,et al.  Local drug delivery for enhancing fracture healing in osteoporotic bone. , 2015, Acta biomaterialia.

[6]  P. Mateo,et al.  Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling. , 2015, Circulation. Heart failure.

[7]  A. Fioravanti,et al.  What about strontium ranelate in osteoarthritis? Doubts and securities , 2014, Modern rheumatology.

[8]  Janet E Brown,et al.  Management of cancer treatment-induced bone loss , 2013, Nature Reviews Rheumatology.

[9]  Long Dai,et al.  Protective Effects of Gallium, Germanium, and Strontium Against Ovariectomized Osteoporosis in Rats , 2013, Biological Trace Element Research.

[10]  J. Klein-Nulend,et al.  Strontium ranelate affects signaling from mechanically-stimulated osteocytes towards osteoclasts and osteoblasts. , 2013, Bone.

[11]  J. Lim,et al.  Bone mineral density deficits in childhood cancer survivors: Pathophysiology, prevalence, screening, and management , 2013, Korean journal of pediatrics.

[12]  S. Boonen,et al.  Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  M. Scherer,et al.  Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats. , 2012, Bone.

[14]  M. Ratajczak,et al.  Adipose Tissue as a Potential Source of Hematopoietic Stem/Progenitor Cells , 2012, Obesity.

[15]  V. Dumas,et al.  Reduction by strontium of the bone marrow adiposity in mice and repression of the adipogenic commitment of multipotent C3H10T1/2 cells. , 2012, Bone.

[16]  S. Hui,et al.  Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy. , 2012, American journal of stem cells.

[17]  W. Lu,et al.  Microarchitecture and Nanomechanical Properties of Trabecular Bone After Strontium Administration in Osteoporotic Goats , 2011, Biological Trace Element Research.

[18]  Q. Fu,et al.  The Effects of Vanadium (V) Absorbed by Coprinus comatus on Bone in Streptozotocin-induced Diabetic Rats , 2011, Biological Trace Element Research.

[19]  Wei Qi,et al.  The Co-effect of Cordyceps sinensis and Strontium on Osteoporosis in Ovariectomized Osteopenic Rats , 2011, Biological Trace Element Research.

[20]  J. Body.  Prevention and treatment of side-effects of systemic treatment: bone loss. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  K. Luk,et al.  In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  M. Rybchyn,et al.  Osteoblasts play key roles in the mechanisms of action of strontium ranelate , 2009, British journal of pharmacology.

[23]  Muhammad Salim,et al.  Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  T. Kohira,et al.  Collaborative work on evaluation of ovarian toxicity. 13) Two- or four-week repeated dose studies and fertility study of PPAR alpha/gamma dual agonist in female rats. , 2009, The Journal of toxicological sciences.

[25]  Makoto Sato,et al.  Collaborative work on evaluation of ovarian toxicity. 7) Effects of 2- or 4- week repeated dose studies and fertility study of cyclophosphamide in female rats. , 2009, The Journal of toxicological sciences.

[26]  S. Ortolani,et al.  Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis , 2009, Osteoporosis International.

[27]  J. Peppercorn.  Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience , 2008 .

[28]  T. Spector,et al.  Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. , 2008, Arthritis and rheumatism.

[29]  F. Saltel,et al.  Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. , 2008, Bone.

[30]  D. Berry,et al.  Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  J. Kanis,et al.  The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women. , 2007, Health technology assessment.

[32]  A James O'Malley,et al.  Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. , 2006, Journal of the National Cancer Institute.

[33]  R. Rizzoli,et al.  Strontium Ranelate Improves Bone Resistance by Increasing Bone Mass and Improving Architecture in Intact Female Rats , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  S. P. Nielsen.  The biological role of strontium , 2004 .

[35]  R. Huiskes,et al.  A three-dimensional digital image correlation technique for strain measurements in microstructures. , 2004, Journal of biomechanics.

[36]  T. Spector,et al.  Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies , 2004, The New England journal of medicine.

[37]  J. Leonidas,et al.  Methotrexate osteopathy , 2004, Skeletal Radiology.

[38]  I. Kaczmarczyk-Sedlak,et al.  [Effect of cyclophosphamide on bone remodeling in rats]. , 2003, Przeglad lekarski.

[39]  L. Feinendegen,et al.  5-Fluorouracil treatment after irradiation impairs recovery of bone marrow functions , 1987, Radiation and environmental biophysics.

[40]  J. Hendry,et al.  Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. , 1985, Anticancer research.